Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

US Patent 10941117 · Granted Mar 9, 2021

Estimated economic value: $5,523,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and pharmaceutical compositions thereof for the treatment of inflammat2025
Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide,2025
Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide,2025
Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide,2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases2024
Compounds and pharmaceutical compositions thereof for the treatment of diseases2024
Compounds and pharmaceutical compositions thereof for the treatment of diseases2024
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2023
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2023
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2023